Literature DB >> 32888226

Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.

Jillian Roberts1, Bethany White2,3, Dena Attalla1, Stephen Ward1, Adrian J Dunlop4,5.   

Abstract

Entities:  

Keywords:  Buprenorphine; CAM2038; COVID-19; depot; jail; long-acting; opioid dependence; opioid use disorder; prison; slow-release

Year:  2020        PMID： 32888226     DOI： 10.1111/add.15244

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  2 in total

1.  Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.

Authors:  Michael Curtis; Justin Berk; Sarah Larney; Josiah D Rich; Mark Stoové
Journal:  Int J Drug Policy       Date:  2022-01-05

Review 2.  Scoping review of mental health in prisons through the COVID-19 pandemic.

Authors:  Luke Johnson; Kerry Gutridge; Julie Parkes; Anjana Roy; Emma Plugge
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.